Skip to main content

Barry Richard

In the past year, 2 open-market purchase filings worth $615.8K and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$615.8K
2 filings
Sold
–
0 filings
Net
+$615.8K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Barry Richard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

FLNA Filana Therapeutics, Inc.

President & CEO7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 24, 2025 (view filing)Nov 204 daysBarry RichardPresident & CEOPPurchase+150.0K$2.76+$414.0K+19.0%938.1K after
Nov 20, 2025 (view filing)Nov 191 dayBarry RichardPresident & CEOPPurchase+73.4K$2.75+$201.8K+10.3%788.1K after
Sep 23, 2025 (view filing)Sep 221 dayBarry RichardPresident & CEOPPurchase+7.17K$2.28+$16.4K+1.0%714.7K after
Sep 22, 2025 (view filing)Sep 18-194 daysBarry RichardPresident & CEOPPurchase+237.9K$2.25+$534.7K+50.7%707.5K after4 lots
Aug 23, 2023 (view filing)Aug 21-222 daysBarry RichardDirectorPPurchase+18.5K$16.67+$307.9K+6.7%293.5K after2 lots
Mar 8, 2023 (view filing)Mar 6-72 daysBarry RichardDirectorPPurchase+88.8K$25.81+$2.29M+47.7%275.0K after2 lots
Aug 25, 2022 (view filing)Aug 232 daysBarry RichardDirectorPPurchase+36.2K$23.79+$860.2K+24.1%186.2K after

SRPT Sarepta Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 6, 2023 (view filing)Nov 33 daysBarry RichardDirectorPPurchase+50.0K$78.81+$3.94M+55.6%140.0K after2 lots